A $16.57 million creditor fallout has exposed deep concerns over buyer’s agent guarantees, licensing standards, and upfront ...

Abpro Holdings, Inc., a biotechnology company, focuses on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease in ...